NCT00005631View on ClinicalTrials.gov

Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1999

Primary Completion Date

November 30, 2002

Study Completion Date

November 30, 2002

Conditions
Lymphoma
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

rituximab

DRUG

carboplatin

DRUG

etoposide

DRUG

ifosfamide

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER